Side-by-side financials for AKAN and DFTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AKAN | DFTX |
|---|---|---|
| Market cap | - | $2.53 B |
| US-listed rank | - | #1936 |
| Net income (latest FY) | - | -$183.79M |
| SEC filings | 188 | 445 |
Full pages: AKANDA CORP. and Definium Therapeutics, Inc., or browse the full rankings.